An observational study in Drug-induced Liver Injury, sponsored by Beijing Ditan Hospital. Status unknown at 1 site in China. Open to participants aged 18 Years to 70 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2014-02-19.
Sponsored by Beijing Ditan Hospital · Observational
The purpose of the study is to establish drug-induced liver injury databases in China, make criteria for Chinese drug-induced liver injury patients and evaluate the application of certain circulating miRNA in diagnosis or treatment of drug-induced liver injury.
Firstly, this study collects some retrospective data. Analyse these data and establish certain unique diagnostic criteria for Chinese. Then collect prospective data and validate the criteria. Otherwise,collect blood sample or other sample of the patients and study certain miRNA in diagnosis or treatment of drug-induced liver injury.
75 studies on the registry are indexed under Chemical and Drug Induced Liver Injury; 20 are open to participants now.
This study's planned enrollment of 800 is above the median of 504 across 38 observational studies indexed under Chemical and Drug Induced Liver Injury.
Browse Chemical and Drug Induced Liver Injury studies →Beijing Ditan Hospital is the lead sponsor of 52 studies on the registry; 2 are open to participants now.
Counted across the registry records on this site, refreshed daily.
community sample and primary care clinic
Exclusion Criteria:
histological features of drug-induced liver injury obtained by liver biopsy
Liver biopsy is the main method
Time frame: within six months of the DILI onset date
clinical features of drug-induced liver injury assessed by serum parameters of liver function
serum parameters of liver function is the focus
Time frame: participants will be followed for the duration of hospital stay, an expected average of 3 weeks
This study is status unknown, as verified in Feb 2014. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Chemical and Drug Induced Liver Injury→
Beijing Ditan Hospital